Reply: Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

od van der Veldt, A A M, Boven, E, van den Eertwegh, A J M, Haanen, J B A G
Izdano 2009

Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

od van der Veldt, A A M, Meijerink, M R, van den Eertwegh, A J M, Haanen, J B A G, Boven, E
Izdano 2010

Defective Differentiation of Myeloid and Plasmacytoid Dendritic Cells in Advanced Cancer Patients is not Normalized by Tyrosine Kinase Inhibition of the Vascular Endothelial Growth...

od van Cruijsen, H., Hoekman, K., Stam, A. G. M., van den Eertwegh, A. J. M., Kuenen, B. C., Scheper, R. J., Giaccone, G., de Gruijl, T. D.
Izdano 2007

Effects of α‐galactosylceramide (KRN7000), interleukin‐12 and interleukin‐7 on phenotype and cytokine profile of human Vα24(+) Vβ11(+) T cells

od Van Der Vliet, H J J, Nishi, N, Koezuka, Y, Peyrat, M A, Von Blomberg, B M E, Van Den Eertwegh, A J M, Pinedo, H M, Giaccone, G, Scheper, R J
Izdano 1999

Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

od van der Veldt, A A M, Boven, E, Helgason, H H, van Wouwe, M, Berkhof, J, de Gast, G, Mallo, H, Tillier, C N, van den Eertwegh, A J M, Haanen, J B A G
Izdano 2008

A phase II study of active specific immunotherapy and5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma

od Baars, A, Claessen, A M E, Wagstaff, J, Giaccone, G, Scheper, R J, Meijer, S, Schakel, M J A G, Gall, H E, Meijer, C J L M, Vermorken, J B, Pinedo, H M, van den Eertwegh, A J M
Izdano 2002

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial

od Mulder, E. E. A. P., de Joode, K., Litière, S., ten Tije, A. J., Suijkerbuijk, K. P. M., Boers-Sonderen, M. J., Hospers, G. A. P., de Groot, J. W. B., van den Eertwegh, A. J. M., Aarts, M. J. B., Piersma, D., van Rijn, R. S., Kapiteijn, E., Vreugdenhil, G., van den Berkmortel, F. W. P. J., Hoop, E. Oomen-de, Franken, M. G., Ryll, B., Rutkowski, P., Sleijfer, S., Haanen, J. B. A. G., van der Veldt, A. A. M.
Izdano u BMC Cancer (2021)